187 related articles for article (PubMed ID: 21604997)
1. Domains of apoE4 required for the biogenesis of apoE-containing HDL.
Vezeridis AM; Chroni A; Zannis VI
Ann Med; 2011 Jun; 43(4):302-11. PubMed ID: 21604997
[TBL] [Abstract][Full Text] [Related]
2. Pathway of biogenesis of apolipoprotein E-containing HDL in vivo with the participation of ABCA1 and LCAT.
Kypreos KE; Zannis VI
Biochem J; 2007 Apr; 403(2):359-67. PubMed ID: 17206937
[TBL] [Abstract][Full Text] [Related]
3. The aminoterminal 1-185 domain of human apolipoprotein E suffices for the de novo biogenesis of apoE-containing HDL-like particles in apoA-I deficient mice.
Petropoulou PA; Gantz DL; Wang Y; Rensen PC; Kypreos KE
Atherosclerosis; 2011 Nov; 219(1):116-23. PubMed ID: 21802082
[TBL] [Abstract][Full Text] [Related]
4. Discrete roles of apoA-I and apoE in the biogenesis of HDL species: lessons learned from gene transfer studies in different mouse models.
Zannis VI; Koukos G; Drosatos K; Vezeridis A; Zanni EE; Kypreos KE; Chroni A
Ann Med; 2008; 40 Suppl 1():14-28. PubMed ID: 18246469
[TBL] [Abstract][Full Text] [Related]
5. Naturally occurring and bioengineered apoA-I mutations that inhibit the conversion of discoidal to spherical HDL: the abnormal HDL phenotypes can be corrected by treatment with LCAT.
Koukos G; Chroni A; Duka A; Kardassis D; Zannis VI
Biochem J; 2007 Aug; 406(1):167-74. PubMed ID: 17506726
[TBL] [Abstract][Full Text] [Related]
6. Substitutions of glutamate 110 and 111 in the middle helix 4 of human apolipoprotein A-I (apoA-I) by alanine affect the structure and in vitro functions of apoA-I and induce severe hypertriglyceridemia in apoA-I-deficient mice.
Chroni A; Kan HY; Kypreos KE; Gorshkova IN; Shkodrani A; Zannis VI
Biochemistry; 2004 Aug; 43(32):10442-57. PubMed ID: 15301543
[TBL] [Abstract][Full Text] [Related]
7. Residues Leu261, Trp264, and Phe265 account for apolipoprotein E-induced dyslipidemia and affect the formation of apolipoprotein E-containing high-density lipoprotein.
Drosatos K; Kypreos KE; Zannis VI
Biochemistry; 2007 Aug; 46(33):9645-53. PubMed ID: 17655277
[TBL] [Abstract][Full Text] [Related]
8. Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL.
Zannis VI; Chroni A; Krieger M
J Mol Med (Berl); 2006 Apr; 84(4):276-94. PubMed ID: 16501936
[TBL] [Abstract][Full Text] [Related]
9. The carboxy-terminal region of apoA-I is required for the ABCA1-dependent formation of alpha-HDL but not prebeta-HDL particles in vivo.
Chroni A; Koukos G; Duka A; Zannis VI
Biochemistry; 2007 May; 46(19):5697-708. PubMed ID: 17447731
[TBL] [Abstract][Full Text] [Related]
10. Probing the pathways of chylomicron and HDL metabolism using adenovirus-mediated gene transfer.
Zannis VI; Chroni A; Kypreos KE; Kan HY; Cesar TB; Zanni EE; Kardassis D
Curr Opin Lipidol; 2004 Apr; 15(2):151-66. PubMed ID: 15017358
[TBL] [Abstract][Full Text] [Related]
11. Discoidal complexes containing apolipoprotein E and their transformation by lecithin-cholesterol acyltransferase.
Gong EL; Nichols AV; Weisgraber KH; Forte TM; Shore VG; Blanche PJ
Biochim Biophys Acta; 1989 Dec; 1006(3):317-28. PubMed ID: 2597674
[TBL] [Abstract][Full Text] [Related]
12. ApoA-IV promotes the biogenesis of apoA-IV-containing HDL particles with the participation of ABCA1 and LCAT.
Duka A; Fotakis P; Georgiadou D; Kateifides A; Tzavlaki K; von Eckardstein L; Stratikos E; Kardassis D; Zannis VI
J Lipid Res; 2013 Jan; 54(1):107-15. PubMed ID: 23132909
[TBL] [Abstract][Full Text] [Related]
13. Regulation of reconstituted high density lipoprotein structure and remodeling by apolipoprotein E.
Rye KA; Bright R; Psaltis M; Barter PJ
J Lipid Res; 2006 May; 47(5):1025-36. PubMed ID: 16452453
[TBL] [Abstract][Full Text] [Related]
14. Lipoproteins produced by ApoE-/- astrocytes infected with adenovirus expressing human ApoE.
Peng D; Song C; Reardon CA; Liao S; Getz GS
J Neurochem; 2003 Sep; 86(6):1391-402. PubMed ID: 12950448
[TBL] [Abstract][Full Text] [Related]
15. An apoA-I mimetic peptide increases LCAT activity in mice through increasing HDL concentration.
Chen X; Burton C; Song X; McNamara L; Langella A; Cianetti S; Chang CH; Wang J
Int J Biol Sci; 2009 Jul; 5(5):489-99. PubMed ID: 19680471
[TBL] [Abstract][Full Text] [Related]
16. LCAT can rescue the abnormal phenotype produced by the natural ApoA-I mutations (Leu141Arg)Pisa and (Leu159Arg)FIN.
Koukos G; Chroni A; Duka A; Kardassis D; Zannis VI
Biochemistry; 2007 Sep; 46(37):10713-21. PubMed ID: 17711302
[TBL] [Abstract][Full Text] [Related]
17. LCAT synthesized by primary astrocytes esterifies cholesterol on glia-derived lipoproteins.
Hirsch-Reinshagen V; Donkin J; Stukas S; Chan J; Wilkinson A; Fan J; Parks JS; Kuivenhoven JA; Lütjohann D; Pritchard H; Wellington CL
J Lipid Res; 2009 May; 50(5):885-93. PubMed ID: 19065001
[TBL] [Abstract][Full Text] [Related]
18. Remodeling of apolipoprotein E-containing spherical reconstituted high density lipoproteins by phospholipid transfer protein.
Settasatian N; Barter PJ; Rye KA
J Lipid Res; 2008 Jan; 49(1):115-26. PubMed ID: 17921435
[TBL] [Abstract][Full Text] [Related]
19. apoE3[K146N/R147W] acts as a dominant negative apoE form that prevents remnant clearance and inhibits the biogenesis of HDL.
Fotakis P; Vezeridis A; Dafnis I; Chroni A; Kardassis D; Zannis VI
J Lipid Res; 2014 Jul; 55(7):1310-23. PubMed ID: 24776540
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein A-I-stimulated apolipoprotein E secretion from human macrophages is independent of cholesterol efflux.
Kockx M; Rye KA; Gaus K; Quinn CM; Wright J; Sloane T; Sviridov D; Fu Y; Sullivan D; Burnett JR; Rust S; Assmann G; Anantharamaiah GM; Palgunachari MN; Katz SL; Phillips MC; Dean RT; Jessup W; Kritharides L
J Biol Chem; 2004 Jun; 279(25):25966-77. PubMed ID: 15066991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
